Parmantier & Cie. GmbH | Finanzwire

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Headlines Articles Press releases Parmantier & Cie. GmbH

Home
Companies
Parmantier & Cie. GmbH

BRIEF

published on 07/08/2025 at 12:48, 4 months 27 days ago

DWK Deutsche Wasserkraft: Germany's Sole Run-of-River Hydropower Firm Analyzed

Sustainable Energy Hydropower DWK Deutsche Wasserkraft Norway Energy Market NordVest Partnership
PRESS RELEASE

published on 07/08/2025 at 12:43, 4 months 27 days ago

DWK Deutsche Wasserkraft in Focus: First Research on Germany’s Only Pure-Play Hydropower Company
Parmantier & Cie. Research releases inaugural report on DWK Deutsche Wasserkraft AG, Germany’s only run-of-river hydropower company. Strategic partnership with NordVest strengthens business model for sustainable energy generation

Sustainable Energy Hydropower DWK Deutsche Wasserkraft AG NordVest Partnership Parmantier & Cie. Research
BRIEF

published on 06/23/2025 at 12:47, 5 months 11 days ago

CLINUVEL's Strategic Moves: CEO's Return and North American Expansion

North American Expansion M&A Strategy CLINUVEL Pharmaceuticals Vitiligo Treatment SCENESSE Approval
PRESS RELEASE

published on 06/23/2025 at 12:42, 5 months 11 days ago

CLINUVEL Update: CEO Comeback & US Expansion Drive: Vitiligo approval and M&A as growth catalysts in North America
CLINUVEL Pharmaceuticals Ltd. sets key strategic signals with CEO Dr. Philippe Wolgen's return and expansion into the North American market, targeting vitiligo approval and M&A for growth catalysts. Analysts confirm strong position and target price

M&A Activities CLINUVEL Pharmaceuticals Ltd. CEO Comeback North American Market Expansion Vitiligo Approval
BRIEF

published on 05/19/2025 at 11:15, 6 months 16 days ago

INDUS Holding AG Showcases Resilience Amid Market Challenges

Growth Strategy Investment Platform Strategic Acquisitions Market Resilience INDUS Holding
PRESS RELEASE

published on 05/19/2025 at 11:10, 6 months 16 days ago

INDUS Holding AG: Resilient, Focused, and Undervalued – PARMANTIER & CIE. Reiterates Buy Recommendation
Parmantier & Cie. reaffirms Buy recommendation for INDUS Holding AG citing resilience, growth trajectory, and solid balance sheet amidst challenges and strategic acquisitions

Strategic Acquisitions INDUS Holding AG Growth Trajectory Resilient Solid Balance Sheet
BRIEF

published on 03/07/2025 at 16:32, 8 months 28 days ago

CLINUVEL Pharmaceuticals Shows Strong Financial Growth

Financial Results North America Expansion CLINUVEL Growth Philippe Wolgen Vitiligo Therapy
PRESS RELEASE

published on 03/07/2025 at 16:27, 8 months 28 days ago

CLINUVEL: Record Half-Year Confirms Growth Trajectory – PARMANTIER & CIE. Presents Latest Research Study on CLINUVEL Pharmaceuticals' Half-Year Results
CLINUVEL Pharmaceuticals Ltd. reports record-breaking figures for H1 of fiscal year 2025, surpassing market expectations with strong revenue and EPS growth. Dr. Philippe Wolgen's leadership and strategic foresight driving sustainable success

Revenue Increase CLINUVEL Pharmaceuticals Record-breaking Figures Dr. Philippe Wolgen Strategic Foresight
BRIEF

published on 02/25/2025 at 11:01, 9 months 7 days ago

INDUS Holding AG: Strong Prospects Affirmed by Parmantier & Cie.

Acquisitions Share Buyback Investment Strategy INDUS Holding AG Financial Growth
PRESS RELEASE

published on 02/25/2025 at 10:56, 9 months 7 days ago

PARMANTIER&CIE.: INDUS Holding AG Continues Growth Path – Buy Recommendation Confirmed
PARMANTIER&CIE. reaffirms buy recommendation for INDUS Holding AG, citing strong financial figures, acquisitions, and share buyback program. Detailed growth strategy outlook to be presented on March 24 & 25, 2025

Growth Strategy Acquisitions Financial Figures INDUS Holding AG PARMANTIER&CIE.

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 12 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 17 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 47 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 42 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 47 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 47 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 17 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 56 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 22 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 32 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 47 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 2 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 3 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE